---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008734"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:44:26.630767+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences shareholders elect all three Class I directors and ratify Deloitte as auditor

## Summary
- Jeffrey S. Aronin, R. Mark Graf, and Jeffrey M. Dayno elected as Class I directors with votes ranging from 18.3M to 20.6M for.
- Ratification of Deloitte & Touche LLP as independent auditor for 2024 passed with 40.2M votes for, 495k against, 12,722 abstain.
- Approximately 40.7M shares (quorum) represented at the 2024 Annual Meeting held May 29, 2024.
- All director nominees will serve until the 2027 Annual Meeting.

## SEC filing metadata
- accession: 0001558370-24-008734
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/0001558370-24-008734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/hrmy-20240529x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008734
- JSON: https://secwatch.observer/filing/0001558370-24-008734.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008734.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.